Congenital Heart Disease is when there are problems with the heart at birth. Accounting for the most birth defects, Congenital Heart Disease is divided into two types: cyanotic, which is when the skin turns blue because lack of oxygen, and non-cyanotic. Congenital Heart Disease is still being researched, but some causes may include exposure to chemicals, alcohol, infections, and high blood sugar during pregnancy. Symptoms of Congenital Heart Disease are not always apparent right away, but some conditions can be diagnosed from a pregnancy ultrasound. Treatments from Congenital Heart Disease vary on the type of condition, but some can go untreated or they can be treated with medications or surgery.
Congenital Heart Disease Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Congenital Heart Disease below!
For more information on how to use Laverne, please read the How to Guide.
We have 1420 products for the study of Congenital Heart Disease that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Congenital Heart Disease is also known as Congenital Cardiac Disorders, Congenital Heart Disorder, Heart Diseases, Congenital.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.